Two listings, same compound, same stated milligrams, and a price gap of three or four times. Some of that gap is margin and some of it is real. These are the parts that are real, and they are worth knowing because they also tell you what to ask.
Milligrams on a label are not milligrams of peptide
This is the largest single factor and the least visible one. Material purified by reversed-phase chromatography is isolated as a salt, usually trifluoroacetate, and lyophilised powder also holds absorbed water. Both add weight without adding peptide.
A label reading "10 mg" can mean ten milligrams of powder, of which the peptide fraction might be eighty-something percent, or ten milligrams of peptide with the salt on top. Those are different products at the same label. The figure that resolves it is net peptide content, which is a separate line from chromatographic purity: purity is about the detected peaks, net content is about the weighed mass. Our note on what else is in the vial covers the rest.
A vial that looks thirty percent cheaper and reports no net content may be the same price per milligram of actual peptide, or more. Without the line you cannot tell, which is the point.
Length, and the cost of the last few percent
Every residue in a synthesis is a coupling step, and every step can fail to go to completion. The usual failure gives a deletion sequence, a chain missing one residue, which differs from the target by a single amino acid and leaves the column at almost the same time.
Separating those from the product is where purification cost lives, and it is not linear. Taking a crude mixture to 95 percent is routine; taking the same material from 95 to 99 can mean discarding a large share of what you made. So a long peptide at a high purity figure is expensive for reasons that have nothing to do with branding, and a short one at the same figure is not. Purity percentages are not comparable across lengths, which our note on peptide length puts in context.
Somebody paid for the analysis
HPLC and mass spectrometry are instrument time, and batch-specific testing means paying for it on each batch instead of once on a representative one. A generic certificate is cheaper to produce because it is produced once.
This shows up directly in price, and it is the difference you are looking at when one supplier can give you a document with your batch number on it and another gives you a specimen. Our note on reading a certificate covers the distinction between a specification and a result.
Batch size moves the number both ways
Fixed costs per batch spread over more vials, so a larger run is cheaper per unit. That is ordinary manufacturing arithmetic and it works in a buyer's favour.
It also sets a limit on what small-batch material can cost, which is worth remembering when a price looks implausible and not merely low. A price well below what the chemistry plus the testing would cost is information, though the honest version of that observation is that it is a reason to ask what was skipped, not a conclusion about what was.
Shipping and storage are part of the price
Lyophilised peptides are shipped cold and stored cold, and both cost money that lands somewhere in the figure you see. A seller shipping from domestic stock has already paid to hold that stock under condition; one drop-shipping from abroad has not, and the difference shows up as a lower price and a longer, less controlled journey.
Neither arrangement is wrong, and the relevant question is which one you are buying. Degradation proceeds with time and temperature, so a cheaper vial that spent three weeks in transit at ambient temperature is a different product from the same vial held cold, even with identical certificates. The certificate is dated for this reason. Our note on storage covers the routes.
What is not a reason
Three things get priced in that should not be.
A CAS number does not make a compound more expensive to make. It is an index entry, assigned when a substance is catalogued, and our validator plus a lookup is all it takes to check one.
Depth of published literature is a property of a compound's history. A compound described decades ago and one reported recently can cost the same to synthesise.
Molecular weight on its own says little. A heavy molecule is not automatically harder to make than a light one; the number of coupling steps and the difficulty of the purification are what matter, and those do not follow from mass.
What this means for comparing two listings
The comparable unit is milligrams of peptide, not milligrams of powder, and you cannot compute it without a net content figure. So the first question on a cheap listing is not "why so cheap" but "what is the net peptide content, and on which batch".
After that, ask whether the certificate carries your batch number, whether a method sits next to each figure, and whether identity is reported as well as purity. Our checklist is the same seven checks in a form you can tick off. A supplier who answers all of them and is still more expensive has told you where the money went.
Research use only
All products sold by Codex Research are strictly for laboratory research and development. They are not for human or animal consumption and are not intended to diagnose, treat, cure, or prevent any disease.
Check this against a real batch
Every compound in the catalog lists its formula, molecular weight and CAS number, and every batch we ship has a certificate you can look up by number.
Frequently asked questions
Why do research peptide prices vary so much for the same compound?
Mainly net peptide content, the length of the synthesis, whether batch-specific testing was paid for, and batch size. The first is the largest and the least visible, because milligrams on a label are milligrams of powder, not of peptide.
What is net peptide content and why does it affect price?
The share of the weighed powder that is peptide, once counterion and absorbed water are set aside. A vial reporting no net content figure cannot be compared on price per milligram of peptide, which is the unit you are buying.
Why does peptide length change the cost?
Every residue is a coupling step that can fail, producing deletion sequences that are hard to separate. Going from 95 to 99 percent purity can mean discarding much of what was made, and that cost rises with length.
Does batch-specific testing make a product more expensive?
Yes. Testing each batch means paying for instrument time on each one instead of once on a representative run. That difference is visible as the gap between a certificate with your batch number and a specimen document.
Does having a CAS number make a compound cost more?
No. A CAS number is an index entry assigned when a substance is catalogued. It says nothing about how difficult the compound is to synthesise or purify.
Is a very low price proof that something was skipped?
It is a reason to ask, not a conclusion. The useful questions are what the net peptide content is and whether the certificate carries your batch number.
References
- Dong, M.W. (2006). Modern HPLC for Practicing Scientists. Wiley.
- Merrifield, R.B. (1963). Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. Journal of the American Chemical Society, 85(14), 2149-2154.
- Swartz, M.E., & Krull, I.S. (2012). Handbook of Analytical Validation. CRC Press.
- Manning, M.C., Chou, D.K., Murphy, B.M., Payne, R.W., & Katayama, D.S. (2010). Stability of protein pharmaceuticals: an update. Pharmaceutical Research, 27(4), 544-575.